University of Rochester Medical Center, Rochester, NY, USA.
University of Vermont Medical Center, Burlington, VT, USA.
Clin Pediatr (Phila). 2020 Oct;59(12):1058-1068. doi: 10.1177/0009922820930357. Epub 2020 Jun 29.
The objectives of this study were to assess the contextual factors, practice strategies, and sustainability of interventions implemented during a national quality improvement (QI) project to raise human papillomavirus (HPV) vaccination rates. We conducted semistructured interviews with positive deviant practices that successfully reduced missed opportunities by ≥20% for HPV vaccination in the prior year. We assessed leadership support, motivators, interventions used, and sustainability. Key themes related to QI teams included strong leadership support, multidisciplinary teams, having a practice champion, and a collaborative environment. Themes related to the interventions included using a presumptive bundled recommendation for all appropriate vaccines at age 11, previsit planning, and reminders for preventive visits, which were sustainable for most practices 1-year postintervention. Both internal practice-level factors (multidisciplinary teams, collaboration, and previsit planning) and organizational factors (institutional support and health system-level reminders for preventive visits) were key to a successful QI intervention to improve HPV vaccination.
本研究的目的是评估在全国质量改进 (QI) 项目中实施干预措施的背景因素、实践策略和可持续性,以提高人乳头瘤病毒 (HPV) 疫苗接种率。我们对在过去一年中成功将 HPV 疫苗接种错失机会减少 ≥20% 的积极异常实践进行了半结构化访谈。我们评估了领导力支持、激励因素、使用的干预措施和可持续性。与 QI 团队相关的关键主题包括强有力的领导力支持、多学科团队、有实践冠军和协作环境。与干预措施相关的主题包括对所有合适的疫苗在 11 岁时使用假定的捆绑推荐、预访计划和预防访问的提醒,这些措施在干预后 1 年内对大多数实践是可持续的。内部实践层面的因素(多学科团队、协作和预访计划)和组织层面的因素(机构支持和卫生系统层面预防访问的提醒)是成功实施 QI 干预以提高 HPV 疫苗接种率的关键。